Loading…

Suppression of Human Immunodeficiency Virus Expression in Chronically Infected Monocytic Cells by Glutathione, Glutathione Ester, and N-Acetylcysteine

The effects of glutathione (GSH), glutathione ester (GSE), and N-acetyl-L-cysteine (NAC) on the induction of human immunodeficiency virus (HIV) expression were investigated in the chronically infected monocytic U1 cell line, a previously described cellular model for HIV latency. U1 cells constitutiv...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS 1991-02, Vol.88 (3), p.986-990
Main Authors: Kalebic, Thea, Kinter, Audrey, Poli, Guido, Anderson, Mary E., Meister, Alton, Fauci, Anthony S.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c579t-8d127e9a9fe1dbdd1976e68a71ebc5d8b0fadcf6dbbfa30f878ff6d0c00679ee3
cites
container_end_page 990
container_issue 3
container_start_page 986
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 88
creator Kalebic, Thea
Kinter, Audrey
Poli, Guido
Anderson, Mary E.
Meister, Alton
Fauci, Anthony S.
description The effects of glutathione (GSH), glutathione ester (GSE), and N-acetyl-L-cysteine (NAC) on the induction of human immunodeficiency virus (HIV) expression were investigated in the chronically infected monocytic U1 cell line, a previously described cellular model for HIV latency. U1 cells constitutively express low levels of virus, which can be increased by phorbol 12-myristate 13-acetate (PMA), tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and other inducers. GSH, GSE, and NAC suppressed in a dose-dependent fashion the induction of HIV expression mediated by PMA, TNF-α, and IL-6, in the absence of cytotoxic or cytostatic effects. Reverse transcriptase activity, inducible by PMA, TNF-α, or IL-6, was decreased by 80-90% after pretreatment with GSH, GSE, or NAC. The induction of total HIV protein synthesis was also decreased appreciably after pretreatment with GSH, GSE, or NAC. The accumulation of HIV mRNA was substantially suppressed after pretreatment with NAC but to a lesser extent after pretreatment with GSH or GSE. Although PMA induces the expression of TNF-α in U1 cells, the suppressive effect of GSH, GSE, and NAC on PMA-induced HIV expression in U1 cells was not associated with the inhibition of TNF-α expression. The present findings, which elucidate relationships between cellular GSH and HIV expression, suggest that therapy with thiols may be of value in the treatment of HIV infection.
doi_str_mv 10.1073/pnas.88.3.986
format article
fullrecord <record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1073_pnas_88_3_986</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>2356111</jstor_id><sourcerecordid>2356111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c579t-8d127e9a9fe1dbdd1976e68a71ebc5d8b0fadcf6dbbfa30f878ff6d0c00679ee3</originalsourceid><addsrcrecordid>eNp9kU1vEzEQhlcIVNLCkRtIvsCpG-z9si1xqaLQRipw4ONqee0xcbVrp7YXdf9Ify8bJU3ChZM1fp6ZsfVm2RuC5wTT8uPGyThnbF7OOWueZTOCOcmbiuPn2QzjguasKqqX2XmMdxhjXjN8lp0RiitS0ln2-H3YbALEaL1D3qCboZcOrfp-cF6DscqCUyP6ZcMQ0fLhoFqHFuvgnVWy60a0cgZUAo2-eOfVmKxCC-i6iNoRXXdDkmk9dcHlaYGWMUG4RNJp9DW_UpDGTo3TnXXwKnthZBfh9f68yH5-Xv5Y3OS3365Xi6vbXNWUp5xpUlDgkhsgutWacNpAwyQl0KpasxYbqZVpdNsaWWLDKDNThRXGDeUA5UX2aTd3M7Q9aAUuBdmJTbC9DKPw0op_ibNr8dv_ETXmJZ_aP-zbg78fICbR26imj0sHfoiCNJgwWm3FfCeq4GMMYA4rCBbbGMU2RsGYKMUU4-S_O33X0d7lNvH3ey7jlIAJ0ikbjxpnRc1YfeJtxz_hpzXCDF2X4CFN3tv_eEd8F5MPB16UdUMIKf8CjKHNCA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16018749</pqid></control><display><type>article</type><title>Suppression of Human Immunodeficiency Virus Expression in Chronically Infected Monocytic Cells by Glutathione, Glutathione Ester, and N-Acetylcysteine</title><source>Open Access: PubMed Central</source><source>JSTOR Archival Journals and Primary Sources Collection</source><creator>Kalebic, Thea ; Kinter, Audrey ; Poli, Guido ; Anderson, Mary E. ; Meister, Alton ; Fauci, Anthony S.</creator><creatorcontrib>Kalebic, Thea ; Kinter, Audrey ; Poli, Guido ; Anderson, Mary E. ; Meister, Alton ; Fauci, Anthony S.</creatorcontrib><description>The effects of glutathione (GSH), glutathione ester (GSE), and N-acetyl-L-cysteine (NAC) on the induction of human immunodeficiency virus (HIV) expression were investigated in the chronically infected monocytic U1 cell line, a previously described cellular model for HIV latency. U1 cells constitutively express low levels of virus, which can be increased by phorbol 12-myristate 13-acetate (PMA), tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and other inducers. GSH, GSE, and NAC suppressed in a dose-dependent fashion the induction of HIV expression mediated by PMA, TNF-α, and IL-6, in the absence of cytotoxic or cytostatic effects. Reverse transcriptase activity, inducible by PMA, TNF-α, or IL-6, was decreased by 80-90% after pretreatment with GSH, GSE, or NAC. The induction of total HIV protein synthesis was also decreased appreciably after pretreatment with GSH, GSE, or NAC. The accumulation of HIV mRNA was substantially suppressed after pretreatment with NAC but to a lesser extent after pretreatment with GSH or GSE. Although PMA induces the expression of TNF-α in U1 cells, the suppressive effect of GSH, GSE, and NAC on PMA-induced HIV expression in U1 cells was not associated with the inhibition of TNF-α expression. The present findings, which elucidate relationships between cellular GSH and HIV expression, suggest that therapy with thiols may be of value in the treatment of HIV infection.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.88.3.986</identifier><identifier>PMID: 1704137</identifier><identifier>CODEN: PNASA6</identifier><language>eng</language><publisher>Washington, DC: National Academy of Sciences of the United States of America</publisher><subject>Acetylcysteine - pharmacology ; AIDS ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral Agents ; Biological and medical sciences ; Cell Line ; Cell lines ; City states ; cytotoxicity ; glutathione ; Glutathione - analogs &amp; derivatives ; Glutathione - pharmacology ; HIV ; HIV - drug effects ; HIV - genetics ; HIV - physiology ; Humans ; Interleukin-6 - pharmacology ; Kinetics ; Medical sciences ; Messenger RNA ; monocytes ; N-acetylcysteine ; Pharmacology. Drug treatments ; phorbol 12-myristate 13-acetate diester ; Pretreatment ; Protein synthesis ; Reverse Transcriptase Inhibitors ; RNA ; RNA, Messenger - genetics ; T lymphocytes ; Tetradecanoylphorbol Acetate - pharmacology ; Thiols ; tumor necrosis factor ; Tumor Necrosis Factor-alpha - pharmacology</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1991-02, Vol.88 (3), p.986-990</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c579t-8d127e9a9fe1dbdd1976e68a71ebc5d8b0fadcf6dbbfa30f878ff6d0c00679ee3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/88/3.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/2356111$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/2356111$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793,58238,58471</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19825885$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1704137$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kalebic, Thea</creatorcontrib><creatorcontrib>Kinter, Audrey</creatorcontrib><creatorcontrib>Poli, Guido</creatorcontrib><creatorcontrib>Anderson, Mary E.</creatorcontrib><creatorcontrib>Meister, Alton</creatorcontrib><creatorcontrib>Fauci, Anthony S.</creatorcontrib><title>Suppression of Human Immunodeficiency Virus Expression in Chronically Infected Monocytic Cells by Glutathione, Glutathione Ester, and N-Acetylcysteine</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>The effects of glutathione (GSH), glutathione ester (GSE), and N-acetyl-L-cysteine (NAC) on the induction of human immunodeficiency virus (HIV) expression were investigated in the chronically infected monocytic U1 cell line, a previously described cellular model for HIV latency. U1 cells constitutively express low levels of virus, which can be increased by phorbol 12-myristate 13-acetate (PMA), tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and other inducers. GSH, GSE, and NAC suppressed in a dose-dependent fashion the induction of HIV expression mediated by PMA, TNF-α, and IL-6, in the absence of cytotoxic or cytostatic effects. Reverse transcriptase activity, inducible by PMA, TNF-α, or IL-6, was decreased by 80-90% after pretreatment with GSH, GSE, or NAC. The induction of total HIV protein synthesis was also decreased appreciably after pretreatment with GSH, GSE, or NAC. The accumulation of HIV mRNA was substantially suppressed after pretreatment with NAC but to a lesser extent after pretreatment with GSH or GSE. Although PMA induces the expression of TNF-α in U1 cells, the suppressive effect of GSH, GSE, and NAC on PMA-induced HIV expression in U1 cells was not associated with the inhibition of TNF-α expression. The present findings, which elucidate relationships between cellular GSH and HIV expression, suggest that therapy with thiols may be of value in the treatment of HIV infection.</description><subject>Acetylcysteine - pharmacology</subject><subject>AIDS</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral Agents</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Cell lines</subject><subject>City states</subject><subject>cytotoxicity</subject><subject>glutathione</subject><subject>Glutathione - analogs &amp; derivatives</subject><subject>Glutathione - pharmacology</subject><subject>HIV</subject><subject>HIV - drug effects</subject><subject>HIV - genetics</subject><subject>HIV - physiology</subject><subject>Humans</subject><subject>Interleukin-6 - pharmacology</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Messenger RNA</subject><subject>monocytes</subject><subject>N-acetylcysteine</subject><subject>Pharmacology. Drug treatments</subject><subject>phorbol 12-myristate 13-acetate diester</subject><subject>Pretreatment</subject><subject>Protein synthesis</subject><subject>Reverse Transcriptase Inhibitors</subject><subject>RNA</subject><subject>RNA, Messenger - genetics</subject><subject>T lymphocytes</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Thiols</subject><subject>tumor necrosis factor</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNp9kU1vEzEQhlcIVNLCkRtIvsCpG-z9si1xqaLQRipw4ONqee0xcbVrp7YXdf9Ify8bJU3ChZM1fp6ZsfVm2RuC5wTT8uPGyThnbF7OOWueZTOCOcmbiuPn2QzjguasKqqX2XmMdxhjXjN8lp0RiitS0ln2-H3YbALEaL1D3qCboZcOrfp-cF6DscqCUyP6ZcMQ0fLhoFqHFuvgnVWy60a0cgZUAo2-eOfVmKxCC-i6iNoRXXdDkmk9dcHlaYGWMUG4RNJp9DW_UpDGTo3TnXXwKnthZBfh9f68yH5-Xv5Y3OS3365Xi6vbXNWUp5xpUlDgkhsgutWacNpAwyQl0KpasxYbqZVpdNsaWWLDKDNThRXGDeUA5UX2aTd3M7Q9aAUuBdmJTbC9DKPw0op_ibNr8dv_ETXmJZ_aP-zbg78fICbR26imj0sHfoiCNJgwWm3FfCeq4GMMYA4rCBbbGMU2RsGYKMUU4-S_O33X0d7lNvH3ey7jlIAJ0ikbjxpnRc1YfeJtxz_hpzXCDF2X4CFN3tv_eEd8F5MPB16UdUMIKf8CjKHNCA</recordid><startdate>19910201</startdate><enddate>19910201</enddate><creator>Kalebic, Thea</creator><creator>Kinter, Audrey</creator><creator>Poli, Guido</creator><creator>Anderson, Mary E.</creator><creator>Meister, Alton</creator><creator>Fauci, Anthony S.</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M81</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>19910201</creationdate><title>Suppression of Human Immunodeficiency Virus Expression in Chronically Infected Monocytic Cells by Glutathione, Glutathione Ester, and N-Acetylcysteine</title><author>Kalebic, Thea ; Kinter, Audrey ; Poli, Guido ; Anderson, Mary E. ; Meister, Alton ; Fauci, Anthony S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c579t-8d127e9a9fe1dbdd1976e68a71ebc5d8b0fadcf6dbbfa30f878ff6d0c00679ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Acetylcysteine - pharmacology</topic><topic>AIDS</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral Agents</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Cell lines</topic><topic>City states</topic><topic>cytotoxicity</topic><topic>glutathione</topic><topic>Glutathione - analogs &amp; derivatives</topic><topic>Glutathione - pharmacology</topic><topic>HIV</topic><topic>HIV - drug effects</topic><topic>HIV - genetics</topic><topic>HIV - physiology</topic><topic>Humans</topic><topic>Interleukin-6 - pharmacology</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Messenger RNA</topic><topic>monocytes</topic><topic>N-acetylcysteine</topic><topic>Pharmacology. Drug treatments</topic><topic>phorbol 12-myristate 13-acetate diester</topic><topic>Pretreatment</topic><topic>Protein synthesis</topic><topic>Reverse Transcriptase Inhibitors</topic><topic>RNA</topic><topic>RNA, Messenger - genetics</topic><topic>T lymphocytes</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Thiols</topic><topic>tumor necrosis factor</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kalebic, Thea</creatorcontrib><creatorcontrib>Kinter, Audrey</creatorcontrib><creatorcontrib>Poli, Guido</creatorcontrib><creatorcontrib>Anderson, Mary E.</creatorcontrib><creatorcontrib>Meister, Alton</creatorcontrib><creatorcontrib>Fauci, Anthony S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kalebic, Thea</au><au>Kinter, Audrey</au><au>Poli, Guido</au><au>Anderson, Mary E.</au><au>Meister, Alton</au><au>Fauci, Anthony S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suppression of Human Immunodeficiency Virus Expression in Chronically Infected Monocytic Cells by Glutathione, Glutathione Ester, and N-Acetylcysteine</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1991-02-01</date><risdate>1991</risdate><volume>88</volume><issue>3</issue><spage>986</spage><epage>990</epage><pages>986-990</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><coden>PNASA6</coden><abstract>The effects of glutathione (GSH), glutathione ester (GSE), and N-acetyl-L-cysteine (NAC) on the induction of human immunodeficiency virus (HIV) expression were investigated in the chronically infected monocytic U1 cell line, a previously described cellular model for HIV latency. U1 cells constitutively express low levels of virus, which can be increased by phorbol 12-myristate 13-acetate (PMA), tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and other inducers. GSH, GSE, and NAC suppressed in a dose-dependent fashion the induction of HIV expression mediated by PMA, TNF-α, and IL-6, in the absence of cytotoxic or cytostatic effects. Reverse transcriptase activity, inducible by PMA, TNF-α, or IL-6, was decreased by 80-90% after pretreatment with GSH, GSE, or NAC. The induction of total HIV protein synthesis was also decreased appreciably after pretreatment with GSH, GSE, or NAC. The accumulation of HIV mRNA was substantially suppressed after pretreatment with NAC but to a lesser extent after pretreatment with GSH or GSE. Although PMA induces the expression of TNF-α in U1 cells, the suppressive effect of GSH, GSE, and NAC on PMA-induced HIV expression in U1 cells was not associated with the inhibition of TNF-α expression. The present findings, which elucidate relationships between cellular GSH and HIV expression, suggest that therapy with thiols may be of value in the treatment of HIV infection.</abstract><cop>Washington, DC</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>1704137</pmid><doi>10.1073/pnas.88.3.986</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 1991-02, Vol.88 (3), p.986-990
issn 0027-8424
1091-6490
language eng
recordid cdi_crossref_primary_10_1073_pnas_88_3_986
source Open Access: PubMed Central; JSTOR Archival Journals and Primary Sources Collection
subjects Acetylcysteine - pharmacology
AIDS
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral Agents
Biological and medical sciences
Cell Line
Cell lines
City states
cytotoxicity
glutathione
Glutathione - analogs & derivatives
Glutathione - pharmacology
HIV
HIV - drug effects
HIV - genetics
HIV - physiology
Humans
Interleukin-6 - pharmacology
Kinetics
Medical sciences
Messenger RNA
monocytes
N-acetylcysteine
Pharmacology. Drug treatments
phorbol 12-myristate 13-acetate diester
Pretreatment
Protein synthesis
Reverse Transcriptase Inhibitors
RNA
RNA, Messenger - genetics
T lymphocytes
Tetradecanoylphorbol Acetate - pharmacology
Thiols
tumor necrosis factor
Tumor Necrosis Factor-alpha - pharmacology
title Suppression of Human Immunodeficiency Virus Expression in Chronically Infected Monocytic Cells by Glutathione, Glutathione Ester, and N-Acetylcysteine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A50%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suppression%20of%20Human%20Immunodeficiency%20Virus%20Expression%20in%20Chronically%20Infected%20Monocytic%20Cells%20by%20Glutathione,%20Glutathione%20Ester,%20and%20N-Acetylcysteine&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Kalebic,%20Thea&rft.date=1991-02-01&rft.volume=88&rft.issue=3&rft.spage=986&rft.epage=990&rft.pages=986-990&rft.issn=0027-8424&rft.eissn=1091-6490&rft.coden=PNASA6&rft_id=info:doi/10.1073/pnas.88.3.986&rft_dat=%3Cjstor_cross%3E2356111%3C/jstor_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c579t-8d127e9a9fe1dbdd1976e68a71ebc5d8b0fadcf6dbbfa30f878ff6d0c00679ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16018749&rft_id=info:pmid/1704137&rft_jstor_id=2356111&rfr_iscdi=true